These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 30261177)

  • 1. Primary Nocturnal Enuresis: A Novel Therapeutic Strategy With Higher Efficacy.
    Jabbour M; Abou Zahr R; Boustany M
    Urology; 2019 Feb; 124():241-247. PubMed ID: 30261177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of desmopressin lyophilisate (MELT) plus anticholinergics combination on functional bladder capacity and therapeutic outcome as the first-line treatment for primary monosymptomatic nocturnal enuresis: A randomized clinical trial.
    Shim M; Bang WJ; Oh CY; Kang MJ; Cho JS
    Investig Clin Urol; 2021 May; 62(3):331-339. PubMed ID: 33834643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating use of higher dose oxybutynin in combination with desmopressin for refractory nocturnal enuresis.
    Berkenwald A; Pires J; Ellsworth P
    J Pediatr Urol; 2016 Aug; 12(4):220.e1-6. PubMed ID: 27373215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy with desmopressin and an anticholinergic medication for nonresponders to desmopressin for monosymptomatic nocturnal enuresis: a randomized, double-blind, placebo-controlled trial.
    Austin PF; Ferguson G; Yan Y; Campigotto MJ; Royer ME; Coplen DE
    Pediatrics; 2008 Nov; 122(5):1027-32. PubMed ID: 18977983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of monotherapy in primary monosymptomatic enuresis: a combined desmopressin and propiverine treatment regimen improves efficacy outcomes.
    Alloussi SH; Mürtz G; Gitzhofer S; Eichel R; Lang C; Madersbacher H; Strugala G; Alloussi S
    BJU Int; 2009 Jun; 103(12):1706-12. PubMed ID: 19154456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of long-term efficacy of desmopressin lyophilisate and enuretic alarm for monosymptomatic enuresis and assessment of predictive factors for success: a randomized prospective trial.
    Önol FF; Guzel R; Tahra A; Kaya C; Boylu U
    J Urol; 2015 Feb; 193(2):655-61. PubMed ID: 25158273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive parameters of response to desmopressin in primary nocturnal enuresis.
    Van Herzeele C; Evans J; Eggert P; Lottmann H; Norgaard JP; Vande Walle J
    J Pediatr Urol; 2015 Aug; 11(4):200.e1-8. PubMed ID: 26059526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary Monosymptomatic Nocturnal Enuresis: Monotherapy vs Combination Therapy.
    Sharifiaghdas F; Sharifiaghdas S; Taheri M
    Urology; 2016 Jul; 93():170-4. PubMed ID: 27018367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing response to desmopressin in patients with monosymptomatic nocturnal enuresis.
    Kamperis K; Van Herzeele C; Rittig S; Vande Walle J
    Pediatr Nephrol; 2017 Feb; 32(2):217-226. PubMed ID: 27071997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desmopressin melt improves response and compliance compared with tablet in treatment of primary monosymptomatic nocturnal enuresis.
    Juul KV; Van Herzeele C; De Bruyne P; Goble S; Walle JV; Nørgaard JP
    Eur J Pediatr; 2013 Sep; 172(9):1235-42. PubMed ID: 23677249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desmopressin versus behavioral modifications as initial treatment of primary nocturnal enuresis.
    Fera P; Lelis MA; Glashan Rde Q; Pereira SG; Bruschini H
    Urol Nurs; 2011; 31(5):286-9. PubMed ID: 22073899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structured desmopressin withdrawal improves response and treatment outcome for monosymptomatic enuretic children.
    Marschall-Kehrel D; Harms TW;
    J Urol; 2009 Oct; 182(4 Suppl):2022-6. PubMed ID: 19695616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Urinary Aquaporin 2 and Plasma Copeptin as Biomarkers of Effectiveness of Desmopressin Acetate for the Treatment of Monosymptomatic Nocturnal Enuresis.
    Hara T; Ohtomo Y; Endo A; Niijima S; Yasui M; Shimizu T
    J Urol; 2017 Oct; 198(4):921-927. PubMed ID: 28457803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased renal concentrating ability after long-term oral desmopressin lyophilisate treatment contributes to continued success for monosymptomatic nocturnal enuresis.
    Ikeda H; Watanabe T; Isoyama K
    Int J Urol; 2017 Sep; 24(9):698-702. PubMed ID: 28636262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there still a role for desmopressin in children with primary monosymptomatic nocturnal enuresis?: a focus on safety issues.
    Van de Walle J; Van Herzeele C; Raes A
    Drug Saf; 2010 Apr; 33(4):261-71. PubMed ID: 20297859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral desmopressin lyophilisate (MELT) for monosymptomatic enuresis: structured versus abrupt withdrawal.
    Ferrara P; Romano V; Cortina I; Ianniello F; Fabrizio GC; Chiaretti A
    J Pediatr Urol; 2014 Feb; 10(1):52-5. PubMed ID: 23791016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constipation in nocturnal enuresis may interfere desmopressin management success.
    Ma Y; Shen Y; Liu X
    J Pediatr Urol; 2019 Apr; 15(2):177.e1-177.e6. PubMed ID: 30594475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desmopressin and oxybutynin in monosymptomatic nocturnal enuresis: a randomized, double-blind, placebo-controlled trial and an assessment of predictive factors.
    Montaldo P; Tafuro L; Rea M; Narciso V; Iossa AC; Del Gado R
    BJU Int; 2012 Oct; 110(8 Pt B):E381-6. PubMed ID: 22313792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of traditional Chinese and Western medicine on nocturnal enuresis in children and indicators of treatment success: Randomized controlled trial.
    Ma Y; Liu X; Shen Y
    Pediatr Int; 2017 Nov; 59(11):1183-1188. PubMed ID: 28891253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of a tertiary center enuresis population, with special emphasis on the relation among nocturnal diuresis, functional bladder capacity and desmopressin response.
    Dehoorne JL; Walle CV; Vansintjan P; Raes AM; De Guchtenaere AR; Van Laecke E; Hoebeke P; Vande Walle JG
    J Urol; 2007 Mar; 177(3):1130-7. PubMed ID: 17296432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.